Earnings summaries and quarterly performance for HEALTHSTREAM.
Executive leadership at HEALTHSTREAM.
Robert A. Frist, Jr.
Chief Executive Officer
Jeffrey D. Cunningham
Senior Vice President and Chief Technology Officer
Kevin P. O’Hara
Executive Vice President, Enterprise Workforce Platform
M. Scott McQuigg
Senior Vice President, Digital & Network Development
Michael M. Collier
Executive Vice President, Corporate Strategy, Development, and Operations
Scott A. Roberts
Senior Vice President and Chief Financial Officer
Scott Fenstermacher
Senior Vice President, Sales
Trisha L. Coady
Executive Vice President, Workforce Solutions
Board of directors at HEALTHSTREAM.
Alex Jahangir, M.D.
Director
Charles E. Beard, Jr.
Director
Deborah Taylor Tate
Director
Frank Gordon
Director
Jeffrey L. McLaren
Director
Linda Rebrovick
Director
Terry Allison Rappuhn
Director
Thompson S. Dent
Lead Independent Director
Research analysts who have asked questions during HEALTHSTREAM earnings calls.
Matthew Hewitt
Craig-Hallum Capital Group LLC
4 questions for HSTM
Richard Close
Canaccord Genuity Group
3 questions for HSTM
Vincent Colicchio
Barrington Research Associates
3 questions for HSTM
Constantine Davides
Citizens JMP
1 question for HSTM
Jared Haase
William Blair & Company
1 question for HSTM
John Pinney
Canaccord Genuity Group Inc.
1 question for HSTM
Ryan Daniels
William Blair & Company, L.L.C.
1 question for HSTM
Stephanie Davis
Barclays
1 question for HSTM
Recent press releases and 8-K filings for HSTM.
- HealthStream, Inc. (HSTM) announced the acquisition of MissionCare Collective LLC on December 15, 2025, adding the nation's largest caregiver network, myCNAjobs.com, as its third Career Network.
- The acquisition price is up to $40 million, comprising a $26 million cash payment at closing, approximately $4 million in HealthStream common stock, and up to $10 million in cash earnout payments over three years.
- HealthStream's CEO, Robert A. Frist, Jr., contributed 146,286 of his personally owned shares, valued at approximately $3.5 million, to over 700 eligible employees.
- Mr. Frist also provided an additional 11,492 shares, valued at approximately $275,000, to cover company costs associated with the equity grants.
- This transaction is expected to result in a $3.5 million compensation expense and $275,000 in administrative expenses for HealthStream in the fourth quarter of 2025.
- The company anticipates a Q4 2025 reduction in operating income by $3.775 million, net income by $2.955 million, and earnings per share by $0.10 due to this contribution.
- HealthStream's CEO, Robert A. Frist, Jr., contributed 146,286 of his personally owned shares, valued at approximately $3.5 million, for the benefit of over 700 eligible employees. These shares are not subject to vesting and will not dilute existing shareholders other than Mr. Frist.
- Mr. Frist also contributed an additional 11,492 shares, valued at approximately $275,000, to cover the estimated company costs associated with the equity grants, such as administrative expenses and employer payroll taxes.
- The company will record a compensation expense of approximately $3.5 million and an additional $275,000 for administrative expenses and employer payroll taxes in the fourth quarter of 2025. This transaction is expected to reduce operating income by $3.775 million, net income by $2.955 million, and earnings per share by $0.10. The only impact on adjusted EBITDA will be the $275,000 for administrative expenses and employer payroll taxes.
- The financial impact is attributed to accounting treatment rather than operational performance, with the CEO covering the associated expenses from outside the company.
- HealthStream's Board of Directors has approved a new share repurchase program for the company's common stock.
- Under this authorization, the company may repurchase up to $10 million of its outstanding shares.
- The program is scheduled to terminate on the earlier of February 26, 2026, or when the maximum dollar amount has been expended.
- HealthStream has announced a new share repurchase program.
- The program authorizes the repurchase of up to $10 million of the company's outstanding common stock.
- Repurchases may be made in the open market, through privately negotiated transactions, or under a Rule 10b5-1 plan.
- The program will terminate on the earlier of February 26, 2026, or when the maximum dollar amount has been expended.
- HealthStream reported record Q3 2025 revenues of $76.5 million, a 4.6% increase year-over-year, with net income at $6.1 million (up 6.3%) and adjusted EBITDA at $19.1 million (up 7.9%).
- The company updated its full-year 2025 financial guidance, narrowing ranges while maintaining previous midpoints, with consolidated revenues expected between $299.5 million and $301.5 million, and adjusted EBITDA between $69.5 million and $71.5 million.
- HealthStream completed the acquisition of Versus twelve LLC on October 8 for $11.2 million in cash, expanding its presence in the payer and health plan market, and noted strong growth in key products like CredentialStream (up 23%) and Shift Wizard (up 29%).
- The company completed its $25 million share repurchase program in Q3 2025 and declared a quarterly cash dividend of $0.31 per share, ending the quarter with a strong cash balance of $92.6 million and no debt.
- HealthStream (HSTM) reported record Q3 2025 revenues of $76.5 million, an increase of 4.6% year-over-year, with net income up 6.3% to $6.1 million and Adjusted EBITDA up 7.9% to $19.1 million.
- The company updated its full-year 2025 financial guidance, narrowing ranges while maintaining midpoints, with expected revenues between $299.5 million and $301.5 million and Adjusted EBITDA between $69.5 million and $71.5 million.
- HSTM completed the acquisition of Versus 12 on October 8th, for an initial $11.2 million in cash, expanding its presence in the payer and health plan market.
- During Q3 2025, HSTM repurchased $6.9 million of its common stock, completing the $25 million share repurchase program, and declared a quarterly cash dividend of $0.31 per share.
- Subscription revenue growth was supported by strong performance in core solutions, with CredentialStream growing by 23%, ShiftWizard by 29%, and CompetencySuite by 18%.
- HealthStream, Inc. reported record quarterly revenues of $76.5 million for Q3 2025, a 4.6% increase from Q3 2024, with diluted earnings per share of $0.20.
- The company's Board of Directors declared a quarterly cash dividend of $0.031 per share, payable on November 28, 2025.
- HealthStream completed its $25.0 million share repurchase program during the three months ended September 30, 2025, having repurchased 905,786 shares year-to-date.
- On October 8, 2025, HealthStream acquired Virsys12 for $13.0 million in cash, expanding its provider data management and credentialing solutions.
- The company updated its full-year 2025 guidance, projecting revenues between $299.5 million and $301.5 million and Adjusted EBITDA between $69.5 million and $71.5 million.
- HealthStream reported record revenues of $76.5 million in the third quarter of 2025, a 4.6% increase from the prior year, with net income of $6.1 million (up 6.3%) and diluted EPS of $0.20 (up from $0.19).
- Adjusted EBITDA for Q3 2025 increased 7.9% to $19.1 million.
- The company completed the acquisition of Virsys12 on October 8, 2025, for $13.0 million in cash, enhancing its provider data management and credentialing solutions.
- HealthStream updated its full-year 2025 guidance, projecting revenues between $299.5 million and $301.5 million and Adjusted EBITDA between $69.5 million and $71.5 million.
- The $25.0 million share repurchase program was fully expended during Q3 2025, and a quarterly cash dividend of $0.031 per share was declared.
- HealthStream (Nasdaq: HSTM) acquired Virsys12, a healthcare technology company, on October 8, 2025.
- Virsys12 specializes in a provider data management suite for payers and health plans, which will expand HealthStream's existing Network by HealthStream™ solution and broader Credentialing application suite.
- The purchase price for Virsys12 was up to $17 million in cash, subject to earnout achievement and a post-closing working capital adjustment.
Quarterly earnings call transcripts for HEALTHSTREAM.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more